Cyclorid-ET Tablet

Overview Cyclorid-ET Tablet

Tranexamic acid combination therapy (Cyclorid-ET equivalent) is indicated for managing menorrhagia. Its mechanism involves inhibiting fibrinolysis, thereby reducing excessive menstrual flow. This medication also enhances platelet aggregation, facilitating clot formation. Dosage should be consistent, regardless of food intake, following your physician's instructions. Continue the prescribed regimen, even after symptom improvement. Missed doses should be taken immediately upon recollection. Abrupt cessation is strongly discouraged without prior medical consultation. Common adverse effects include gastrointestinal upset (nausea, stomach pain, diarrhea), headache, nasal and sinus congestion/inflammation, skin rash, fatigue, and musculoskeletal discomfort. Hydration is encouraged to mitigate dehydration risk. If menstrual flow doesn't improve after three cycles, seek medical advice. Prior to commencing treatment, disclose any kidney issues, uterine bleeding abnormalities, pregnancy, breastfeeding, or concurrent medications. Regular ophthalmological examinations may be necessary during therapy.

Uses of Cyclorid-ET Tablet

Prolonged and profuse uterine bleeding

Major Benefits of Cyclorid-ET Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Cyclorid-ET Tablets can be administered with or without food, though consistent timing is recommended.

Common Side effects of Cyclorid-ET Tablet:

• Nausea
• Stomach pain
• Diarrhea
• Headache
• Nasal congestion (stuffy nose)
• Sinus pain
• Sinus inflammation
• Rash
• Tiredness
• Musculoskeletal (bone, muscle or joint) pain
• Anemia (low number of red blood cells)

How to use Cyclorid-ET Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Cyclorid-ET Tablets can be administered with or without food, though consistent timing is recommended.

How Cyclorid-ET Tablet works:

Cyclorid-ET tablets contain Tranexamic Acid and Ethamsylate, two drugs that work synergistically to manage bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots by inhibiting their degradation, thus reducing excessive blood loss. Ethamsylate, a hemostatic, enhances platelet aggregation, promoting clot formation and controlling hemorrhage, particularly from capillaries.

What if you forget to take Cyclorid-ET Tablet :

Should you forget a Cyclorid-ET Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.